To isolate the direct effects of EZH2 and KMT2D mutations, we utilized the patient-derived lymphoma cell line OCI-Ly7, which carry WT alleles of all the main epigenetic regulators that are known to be recurrently mutated in DLBCL [20,21,37]. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.